Discover
OGN
Organon & Co.
13.81
5500 x 13.80
11000 x 13.81
bid
ask
+
0.06
0.44%
8250 @ 04:00 PM
13.81 +0.00 (0.00%)
| Ytd | 92.61% | |
| 1y | 39.21% |
13.75
day range
13.83
5.70
52 week range
13.81
| Open | 13.76 | Prev Close | 13.75 | Low | 13.75 | High | 13.83 | Mkt Cap | 3.63B |
| Vol | 3.26M | Avg Vol | 2.66M | EPS | 0.78 | P/E | 17.71 | Forward P/E | 3.82 |
| Beta | 1.54 | Short Ratio | 5.45 | Inst. Own | 84.76% | Dividend | 0.08 | Div Yield | 0.58 |
| Ex Div Date | 08-14 | Earning | 11-09 | 50-d Avg | 13.69 | 200-d Avg | 11.03 | 1yr Est | 11.25 |
OGN News
accessnewswire.com
Orogen Royalties Creates a Royalty on the Cibola Copper-Gold Project in British Columbia
VANCOUVER, BC / ACCESS Newswire / October 8, 2026 / (TSXV:OGN)(OTCQX:OGNNF) Orogen Royalties Inc. ("
benzinga.com
Organon Canada Announces Availability Of NDUVRA To Treat Moderate To Severe Atopic Dermatitis
Organon Canada, a global healthcare company, today announces the approval and availability of NDUVRA